Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product

Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product
·2 min read

Teva said Wednesday sales of its biggest moneymaker declined again as generic competition mounts, leading Teva stock into a dive.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting